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Abstract  
 
Background 
HIV epidemiology and intervention uptake among female sex workers (FSW) in sub-Saharan Africa remain poorly 
understood. Data from outreach programmes are a neglected resource.   
Methods 
Analysis of data from FSW consultations with Zimbabwe’s National Sex Work programme, 2009-14. At each visit, 
data were collected on socio-demographic characteristics, HIV testing history, HIV tests conducted by the 
programme and antiretroviral (ARV) history.  Characteristics at first visit and longitudinal data on programme 
engagement, repeat HIV testing and HIV sero-conversion were analysed using a cohort approach. 
Results 
Data were available for 13360 women, 31389 visits, 14579 reported HIV tests, 2750 tests undertaken by the 
programme and 2387 reported ARV treatment initiations.  At first visit, 72% of FSW had tested for HIV; 50% of these 
reported being HIV-positive. Among HIV-positive women, 41% reported being on ARV. 56% of FSW attended the 
programme only once. FSW who had not previously had an HIV positive test had been tested within the last 6 
months 27% of the time during follow up. After testing HIV-positive, women started on ARV at a rate of 23 / 100 
person years of follow-up. Among those with two or more HIV tests, the HIV sero-conversion rate was 9.8 / 100 
person years of follow-up (95% confidence interval 7.1-15.9). 
Conclusions 
Individual-level outreach programme data can be used to estimate HIV incidence and intervention uptake among 
FSW in Zimbabwe. Current data suggest very high HIV prevalence and incidence among this group and help identify 
areas for programme improvement. Further methodological validation is required. 
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Key Messages 
 
- While there are a range approaches to HIV surveillance among high-risk, marginalised groups such as female 
sex workers (FSW) in sub-Saharan Africa, these all have limitations and there remains a highly damaging 
paucity of data from these populations to guide public health action 
 
- Data collected through outreach programmes that provide services to female sex workers are a potentially 
valuable but neglected resource. 
 
- We developed a cohort analysis approach to estimating HIV incidence and intervention uptake among 
female sex workers using data from over 31,000 outreach programme contacts with 13,000 women in 26 
sites covering all provinces in Zimbabwe, 2009-14. 
 
- The data suggest very high incidence (10-12% per year) among female sex workers in Zimbabwe and suggest 
programme retention, repeat HIV testing and linkage to treatment can all be improved. The analysis 
approach could be used to track whether improvements are being realised over time. 
 
- The approach has many potential biases, but these are worthy of better characterisation through further 
study characterisation since all feasible approaches to surveillance among this group are flawed and data 
triangulation is needed. 
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Introduction 
Tracking HIV epidemiology and intervention uptake among populations at high risk of infection is essential. One such 
group are female sex workers (FSW) in sub-Saharan Africa  1. Sex work-related behaviours are illegal and/or 
stigmatised in many countries, including Zimbabwe 2,3. Sex workers in Zimbabwe most commonly solicit clients in 
bars, start sex work at 22-23 years of age and report 2 clients per week. Many experience violence in their work, 
while 65-73% report consistent condom use with transactional partners 4. 
 
General population surveys that ask about these behaviours suffer from social desirability bias, and anyway tend to 
recruit few individuals in these risk categories. The major issue for surveys of this hidden populations is that no 
sampling frame for the target population is available. Location-based 5 or respondent-driven sampling (RDS) 
surveys6,7 that target FSW improve significantly upon convenience samples and are theoretically-based and feasible, 
but remain complex to analyse and interpret. Structural factors, including high mobility, further complicate matters 8 
9. A significant information gap therefore remains which prevents better programming for FSW in Africa. A recent 
systematic review of HIV epidemiology among FSW identified 30 HIV prevalence studies (16 countries, average 
sample size 714 women) but no HIV incidence studies from sub-Saharan Africa since 2007 10. Another review 
identified only seven African studies in five countries on anti-retroviral (ARV) uptake, attrition, adherence and 
outcomes among FSW 11.  
 
Data from outreach programmes are a potential resource. We compiled individual-level programmatic data collected 
from consultations with the Zimbabwean national HIV prevention programme for FSW from 2009-14. Using cohort 
methods we estimated intervention uptake and, among FSW with serial HIV tests, the rate of HIV seroconversion. 
The aim of this paper is not to evaluate the programme; rather we describe our analysis of the data, interpret the 
indicators we develop, and consider strengths and limitations of our approach.  
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Methods 
Setting 
In 2009 we established the ‘Sisters with a Voice’ HIV prevention and sexual and reproductive health services for FSW 
in Harare, Zimbabwe within the National Behaviour Change Programme12. Since then the ‘Sisters’ programme has 
expanded across the country, and provides free access to HIV testing, STI treatment, family planning, HIV prevention 
education, condoms and legal services13. There are six fixed sites in larger towns or cities open on weekdays, with 
mobile teams providing once weekly clinical services to surrounding hotspots or smaller towns (outreach services). 
The programme is supported by trained peer educators and community mobilisation and empowerment activities. 
Peer educators and outreach staff run participatory group meetings with sex workers at all sites (including outreach 
sites) at least once a month. Materials to support group activities are aimed at creating demand for services as well 
as building social cohesion and empowerment. In the case of outreach sites, peer educators are responsible for 
maintaining programme activities in between weekly programme visits. Women attending the programme who are 
HIV-negative are encouraged to re-test every six months, but there is no active follow up of women who default. 
From 2009-2013, access to antiretroviral (ARV) medication increased rapidly across Zimbabwe 14. Over this period 
the programme itself did not initiate women onto antiretroviral treatment (ART) but referred women to public 
services. HIV-positive individuals were eligible to initiate ART when their CD4 count fell below 350cells/ml15.  
Data collection 
At first visit to the programme at any site, women were assigned a unique identifier. At each visit to the programme 
they were asked if they had been to the programme before and if so the file was retrieved and unique ID used to link 
consultations. This linkage was possible both within and across sites; however, as discussed further below, it is 
possible that if women chose to deliberately withhold the fact that they had been previously enrolled some records 
may not have been  linked,  so some women may appear as duplicates in the data. Data were collected on structured 
forms by nursing staff undertaking clinical consultation and subsequently single-entered into a database in Microsoft 
Access. Data on HIV tests conducted by the programme were entered into a separate data file. Socio-demographic 
information included date of birth, marital status and parity, and beginning in mid-2011, educational attainment. At 
all visits, information was collected on whether FSW had ever tested for HIV and the date and result of the most 
recent test, wherever this had been undertaken.  Among women identified as HIV-infected, data were collected at 
each visit on whether and when ARVs had been initiated and if these were currently being taken. We analysed 
information from visits to all 26 sites collected between 11 September 2009, the date of the first visit to the Harare 
clinic, and 14 March 2014, the last visit considered for this analysis. 
Data management 
Date fields were re-coded in “date” format. Dates that were not in a valid format were checked against source data. 
We specified logical queries for valid dates and the result of HIV tests, for example querying when a negative test 
was reported following a positive test. Some events, such as HIV tests, could be reported at more than one 
consultation or might have appeared both as a self-reported test and in the programme testing database. For 
example, if a FSW made several visits to the programme, the same last HIV test may have been reported more than 
once, sometimes at different levels of precision. We harvested the most precise information provided across all visits 
and removed duplicates: for example, September 2010 would be updated by 15 September 2010.  Data related to 
events that occurred prior to first visits to the programme were also collected. For example, the date of the first HIV 
test may have been some years in the past. In these cases, where a precise date was not provided we imputed the 
date as the 1st of the month where month and year were present and 1st January if only the year had been provided. 
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We merged the visit and testing database and identified and removed duplicate HIV tests (by patient ID and date) 
reported in both.  
Finally we excluded women from analysis where we remained concerned about data accuracy. Our approach was 
conservative. For all events occurring on or subsequent to the first visit to the programme we required that full date 
information (dd/mm/yyyy) were present and excluded women with missing data in relation to these dates. Women 
were excluded if they reported taking ARVs but did not report a previous HIV-positive test; if they had an HIV-
negative test after an HIV-positive test; or if they had either an HIV test date or ARV start date that did not have a 
reported month.  Figure 1 shows the flow chart of exclusions. Overall, the original database contained records on 
14,143 FSW. We excluded 808 FSW (6%) from our analysis database because of concerns about the accuracy of data. 
Details of missing data for other variables are provided with the tables. In particular, data collection on educational 
attainment only started some time after the programme had been initiated. 
Data analysis 
Women were assigned to one of five categories that described them on the date of their first visit to the 
programme: (1) never having HIV tested, (2) having previously tested HIV-negative over 6 months ago, (3) having 
previously tested HIV-negative up to 6 months ago, (4) having previously tested HIV-positive but not having 
commenced ARV, and, (5) having previously tested HIV-positive and ever initiated ARV treatment.  
We then analysed data on dates of visits to the programme, HIV tests, the date on which ARVs were initiated, and 
dates over which FSW were aware of their HIV status. Using these dates, we created a data set reflecting an open 
cohort of women visiting the programme. Within the data a personal timeline was constructed for each FSW. The 
“revisit rate” was the proportion of individuals coming for more than one visit to the programme. We calculated the 
median time between first and second visits for those who attended at least twice.  The level of “HIV-negative status 
awareness” was calculated as the proportion of time between first and last visits to the programme during which 
individuals who had not previously had a positive HIV test “knew” their HIV status to be negative. Women were 
considered to “know” their HIV-negative status if they had tested HIV-negative within the previous 6 months.  The 
denominator time was censored if women became HIV-positive.  The “ARV initiation rate” was calculated as the rate 
at which women initiated ARVs among those who reported knowing that they were HIV-positive but not on ARV 
therapy.  The person time at risk was calculated as the time between the first visit where the woman reports being 
HIV-positive (or a positive test conducted by the programme) and the last HIV-negative visit, with censoring at the 
date where women reported initiating ARV. 
We calculated HIV prevalence as the number of positive first tests divided by the number of first HIV tests reported. 
To estimate HIV incidence we restricted our analysis to individuals who had or reported having at least two HIV tests 
after first attending the programme.  We identified individuals who had a positive test result as well as a prior 
negative test since their first visit to the programme, and imputed the date of infection as the mid-point between 
the negative and positive test result.  These individuals contributed time at risk from their first visit until this imputed 
date of sero-conversion.  Women who did not seroconvert contributed time at risk between the first visit and last 
negative test. We also calculated the HIV incidence rate using only HIV tests conducted by the programme. Figure 2 
shows graphically how the timeline for women was constructed. 
We compared “baseline” status and longitudinal indicators across several categories: time periods (pre- and post- 
31st July 2011, which was the approximate mid-date of the period examined here), age, marital status and 
educational attainment. To describe differences between groups we used logistic regression for binary outcome 
variables and Poisson regression for rates, reporting 95% confidence intervals with robust standard errors to account 
for inclusion of data from multiple sites. 
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Ethics approval for the analysis of programme data was obtained from the Medical Research Council of Zimbabwe 
(MRCZ/A/1762) and ethics committees of University College London (4948/001) and London School of Hygiene and 
Tropical Medicine (6524). Since the data were collected from women as part of routine clinical care, individual 
informed consent was not obtained. Data were extracted in anonymised form from the clinical database for analysis. 
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Results 
We recorded 31,389 consultations with 13,360 women (median age at first visit 29 yrs). Most FSW attending the 
programme had secondary education (6,889/9,316, 74.0%) and a high proportion were divorced or separated 
(8,101/13,257 61.1%) (Table 1). Some 28.0% (3,735/13,360) had never previously tested for HIV when they first 
attended the programme, though after July 2011 this proportion was smaller (1,898/8,794, 21.6%). Among those 
who had tested for HIV before their first visit, 50.4% (4,847/9,625) reported having tested positive.  Among those 
who had tested HIV-positive, 41.0% (1,986/4,847) reported previously initiating ARV treatment. Younger FSW (12-25 
years old) were the most likely to have tested HIV-negative within the previous 6 months. Older FSW were more 
likely to be HIV-positive and on treatment. Divorced or widowed FSW were those most likely to be HIV-positive and 
on treatment. 
The highest number of visits made by any individual client was 37, and the highest number of consultations occurred 
at the main clinic in Harare, which was the first clinic to open (12,033 consultations, 38.3% of the total). 7,445 visits 
were by FSW who only attended the programme once (55.7% of individuals), the remainder were follow-up visits by 
5,915 individuals who attended more than once, with a mean of 4 and median of 3 visits, with 2,448 (18.3%) coming 
twice.  The median time between first and second visit was 53 days (Lower-quartile 19, upper-quartile 126), among 
the 5,915 women who attended twice or more. Individuals whose first visit was before July 2011 were more likely to 
come back (see Table 2). Individuals who reported being HIV-positive at baseline were more likely to re-attend (see 
Table 2).  Among those individuals who had an HIV-positive test conducted by the programme (N=1,263), and would 
have therefore been referred to government services, 54.1% were not seen again, while 16.0% (93/580) of those 
who were seen again later reported having started ARVs. 
HIV-negative FSW engaged with the programme had had a negative test within the last 6 months 26.5% of the total 
follow-up time (95% CI: 23.4 - 29.5) (Table 3).  Those who had never previously tested at their first visit to the 
programme were the least likely, during their engagement with the programme, to know their status (19.9% of the 
total follow-up time, 95% CI 17.1 – 22.8). After July 2011 a greater proportion of women were aware of their status: 
among those who first came to the programme after 1 July 2011, FSW knew their status 30.4% of time. The 
programme conducted 2,750 HIV tests, 1,263 (45.9%) of which were positive.  760/14,579 (5.2%) of the HIV tests 
took place within three months of a previous negative test.  Of these, 733 were HIV-negative and 27 were HIV-
positive.   
In total, 355 individuals with an HIV-positive test reported starting ARV therapy during 1,539 person years of follow 
up (rate 23.0 initiations / 100 person years of follow up), calculated from the first time that the programme was 
aware of their HIV-positive status until either their last visit or date of initiating ARV therapy. The ARV initiation rate 
increased with participant age and was highest among individuals who arrived having had an HIV-negative test 
within the previous six months. 
Some 67 women sero-converted following their first visit, among the 605 women who had at least two tests at or 
after their first visit including at least one negative test, and over 686 person years of follow up. Among these 
women, the rate of new infection was 9.8 per 100 person years of follow up (95% CI 7.1 – 15.9). Incidence was lower 
among women aged over 35 (6.0 cases per 100 person years), and in women who had tested for HIV within 6 
months prior to the first visit (7.3 cases per 100 person years).  The incidence rate calculated using only HIV tests 
administered by the programme was 12.5 (95% CI 6.9 – 21.2) per 100 person years of follow-up (24 cases in 193 
person years follow-up).    
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Discussion 
We used individual-level, anonymised data drawn from an outreach programme database to calculate indicators of 
HIV-intervention uptake among women accessing an outreach HIV prevention programme for FSW in 26 sites across 
Zimbabwe, and estimated the rate of HIV sero-conversion among women reporting two or more HIV tests. Given the 
complexity of HIV surveillance among FSW, and the paucity of epidemiological data on this group in Africa, we 
suggest that programme data could be better harnessed to characterise the epidemiology of HIV among FSW and to 
inform public health action.  
 
Establishing population-based measures of HIV-related phenomena among FSW is difficult since it is not possible to 
enumerate and conduct random-sampling-based surveillance 5. Our approach uses outreach programme data and 
has several limitations which we discuss below. However, our analysis also had strengths. We collected longitudinal 
data from a large sample of women self-identifying as FSW. As we discuss below, these women may not be 
representative of all FSW. However, our programme attendees are likely to be more representative of the underlying 
population than the research-cohorts of FSW among whom many studies are conducted 11. Taken at face value the 
data provide strategic information that could guide HIV resource allocation and programming in Zimbabwe. The data 
suggest very high HIV incidence among FSW. Most FSW had previously tested for HIV when they accessed the 
programme. However rates of repeat testing were not optimal. Just over half of FSW seen by the programme did not 
return for a second visit, suggesting retention could be improved. Finally, around 41% of FSW who had previously 
tested positive at first visit had also started ARVs, while HIV-positive FSW started treatment at a rate of 23/100 
person years of engagement with the programme each year. While not all FSW will be eligible at the treatment 
guidelines in place during this time, this reflects another area for potential strengthening: Zimbabwe’s 2013 revision 
of National ART guidelines recommends ART for all HIV-positive SWs regardless of CD4 count 16. 
However, caution is warranted: the methods we describe may suffer from potential biases requiring further 
characterisation. The most obvious limitation of data collected through outreach programmes is that they only offer 
information on FSW accessing the programme. There are several reasons why these women may not be 
representative of the wider FSW population. Those who do not access services may be more at risk of HIV infection 
than those who do, for example their non-access of the programme may be reflective of riskier, more unstable 
lifestyles. Conversely, those accessing services may have higher risk than the underlying population of FSW: for 
example, individuals may be likely to attend services if they suspect recent exposure to HIV infection or have become 
sick. Further, while those who attended these outreach services may be more likely to access health care and stay 
engaged with services, they may not be. We have limited data on the rate with which FSW accessed other clinics or 
private services. Some FSW who did not access the outreach programme were likely accessing the same services 
through other channels. Indeed, over 70% of the FSW attending the programme had previously had an HIV test prior 
to their first engagement with our programme and among those presenting with a prior HIV positive test 41% had 
already initiated ARV. Further, the characteristics of FSW who access the programme may also change over time. 
The balance of these factors influencing who does and does not appear among the recruited sample is hard to 
gauge. These limitations notwithstanding, uncertainties about representativeness also affect all other approaches to 
surveying FSW, such as RDS surveys. 
Another potential limitation is that while we issued each woman with a unique identifier code that could be used to 
identify her at future visits to the programme at any site, this system involved no biometrics or validation and it is 
likely that some individual women appear as duplicates in the dataset. FSW working in Zimbabwe are highly mobile 
and may access the programme at multiple sites. A further limitation with respect to our calculation of HIV incidence 
is that we incorporate information on the self-reported results of HIV tests. We used a longitudinal approach, 
incorporating data from self-reported data on HIV tests in the context of a clinical interview, as opposed to 
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household interviews which may be more prone to reporting bias. Many tests were confirmed through the 
programme.  Although much less precise, our incidence estimate using only tests actually conducted by the 
programme was very similar to our estimate using all reported tests after the first visit.  
There are limited data on HIV and service access among FSW in sub-Saharan Africa with which to compare our data. 
With respect to epidemiological parameters, our estimate that 50% of FSW who had previously tested at first visit 
were HIV positive is in line with our own estimates of HIV prevalence from RDS surveys in 3 sites in 2011 (50-70%) 4 
and in 14 sites in 2013 (mean 56%)17. Global estimates of FSW HIV prevalence suggest this is much higher than in the 
general population1; in Zimbabwe general population HIV prevalence for women aged 15-49 is 15% 18. There are 
little comparable data for FSW HIV incidence from any setting in sub Saharan Africa 19-22, while general population 
HIV incidence in Zimbabwe is estimated at about 1% per annum 23. We estimate a figure 10-12 times higher than this 
among FSW accessing a dedicated HIV prevention programme and reporting multiple HIV tests.  Approximately 70% 
of our sample had ever tested for HIV at their first visit to the programme, 60% prior to July 2011 and 78% after. 
Among the general population in the 2010/11 Zimbabwe Demographic Health Survey, 57%  of all women aged 15-49 
had ever tested, up from 22% in 2005/6 and with higher rates among those aged 20-49 (< 2% of the programme 
attendees were aged below 20) 24. Data from 2008-2010 suggest that 60% of FSW in sub-Saharan Africa had tested in 
the last 12 months 25. HIV testing is available to FSW, even in the absence of targeted services, though there are 
significant barriers to service access in our setting 26 and in others 27. Our estimate that at first visit to the 
programme 41% of HIV-positive FSW were on ARV is similar to the 38% figure reported in a recent systematic review 
11. Overall, data obtained from this programme platform appear compatible with other information currently 
available on FSW. 
Many programmes collect data from clients to support service delivery. In turn, aggregated data are often reported 
to funders or regulatory bodies. However, these statistics often do not reflect the depth of analysis that may be 
possible. We used standard epidemiological techniques to generate a virtual open cohort of women accessing the 
programme and generated a range of useful statistics. The approaches we used are not complex though they require 
care in both data collection and analysis. We advise other programmes to consider this possibility. In 2014 we 
established an electronic data capture platform which has now been rolled out in all sites. Data are uploaded in real 
time. This system will improve data completeness, quality and participant tracking. In future work we plan to 
compare the population accessing the programme with data from 14 RDS surveys in overlapping sites and plan to 
explore geographical and over-time variation in the indicators. These analyses will be used where possible to guide 
and strengthen programme implementation, for example by identifying where testing activities might be 
strengthened, and to provide information for policy makers to inform resource allocation decisions. Finally, the data 
will be leveraged to provide process indicators for an ongoing cluster-randomised trial: the ‘Sisters Antiretroviral 
therapy programme for prevention of HIV: an Integrated response’ (SAPPH-IRE) intervention trial 
(PACTR201312000722390). The combination intervention under study in the trial seeks to improve the accessibility 
of ARV for both prevention and treatment for FSW in Zimbabwe: the programme data platform will provide data on 
whether the intervention has succeeded in improving retention, as well as rates of repeat testing and linkage to ART 
treatment and prevention.   
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Tables and Figures 
 Figure 1: Flow chart of exclusions 
 
 
  
14,143 women 
37,267 visits 
29,007 HIV tests 
7,205 ART initiations  
13,360 women 
31,389 visits 
11,829 self-reported HIV tests  
2750 programme HIV tests 
2,387 ART initiations (906 
imputed, 38%) 
777 women dropped because of logical 
errors (some overlapping):  
 188 ART< first pos HIV test date,  
 27 ART w/o HIV pos date,  
 195 HIV neg test after positive,  
 466 imputed HIV after first visit 
669 undefined HIV results deleted 
Duplicated events dropped.  
40 women with no visits recorded  
2 women with dates only before 22nd 
September 2009 
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Figure 2: Examples of timelines of female sex-worker event histories 
 
   All Data      Programme tests only  
 
Figure 2: This graph shows the timelines of nine women who first attended the clinics after January 2011.  These 
timelines show HIV tests (negative and positive), visits, dates of starting ART, and approximate sero-conversion dates 
calculated as the midpoint between a positive test and the last negative test.  The lines connect the first and the last 
visits.  The timelines on the left use all HIV test data, while on the right only programme tests are used.  As a result, 
the estimated time of sero-conversion – or the estimation of sero-conversion at all – is often different in the two 
data handling approaches.  In the timeline labelled ‘A’ the sero-conversion date is calculated using a negative test 
prior to the first visit, which would not be permitted in our primary incidence estimation procedure, and also 
estimates the sero-conversion date to be prior to the start of follow-up, thus being excluded from all analysis.  
 
A 
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Table 1: Sociodemographic characteristics at first visit of women accessing dedicated FSW STI and HIV prevention services in 26 sites in Zimbabwe, 2009-2012 
 
Total 
 
Never tested at first 
visit 
Previous HIV-negative 
test  > 6 months ago 
HIV-negative test  
< 6 months ago 
Previous positive 
test, not on 
treatment 
Previous positive 
test, & on 
treatment 
 n Col% n Row %s n Row %s n Row %s N Row %s n Row %s 
Total 13,360 100 3,735 28.0 2,348 17.6 2,430 18.2 2,861 21.4 1,986 14.9 
Period of first visit             
 Before 1st July 2011 4,566 34.2 1,837 40.2 683 15.0 497 10.9 1,015 22.2 534 11.7 
 After 1st July 2011 8,794 65.8 1,898 21.6 1,665 18.9 1,933 22.0 1,846 21.0 1,452 16.5 
Age    Col. %  Col. %  Col. %  Col. %  Col. % 
 12-25* 3,815 29.1 1,158 31.5 856 37.1 1,075 45.3 577 20.6 149 7.7 
 26-35 5,941 45.3 1,661 45.1 1,026 44.5 945 39.8 1,473 52.6 836 43.0 
 36+ 3,350 25.6 863 23.4 424 18.4 355 15.0 748 26.8 960 49.4 
Education             
 None / Primary 2,427 26.1 571 27.4 378 21.5 409 20.5 574 29.1 495 33.0 
 Secondary 6,889 74.0 1,517 72.7 1,377 78.5 1,589 79.5 1,402 71.0 1,004 67.0 
Marital Status             
 Cohabiting/Married 351 2.7 82 2.2 86 3.7 76 3.2 61 2.2 46 2.3 
 Divorced/Separated 8,101 61.1 2,290 61.8 1,477 63.4 1,603   66.4 1,730 61.0 1,001 50.8 
 Never married 2,172 16.4 681 18.4 472 20.3 475 19.7 344 12.1 200 10.2 
 Widowed 2,633 19.9 655 17.7 296 12.7 260 10.8 699 24.7 723 36.7 
 
Table 1: 4,044 women have missing education data, 224 have missing age data, and 103 have missing marital status.  Missingness in education is largely due to education 
not having been collected before 2011 (missing in period 1 = 3,773, missing in period 2 = 271). The proportion HIV positive at first visit, by age group, was 19.0% (726/3,815) 
for 12-25 years; 38.9% (2,309/5,941) for 26-35 years; and 51.0% (1,708/3,350) for 36+ years. The proportion who had started ART at first visit, by age group, was 3.9% 
(149/3,815) for 12-25 years; 14.1% (836/5,941) for 26-35 years; and 28.7% (960/3,350) for 36+ years. Note that over the period of the analysis HIV+ women with a CD4 
count of <350cells/ were eligible for ART.  
* While the youngest FSW age recorded in our database is 12 years, in total there were 115 FSW who reported an age under 18 years, and a further 450 aged 18-19 years.
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Table 2: Proportion of women re-attending within 12 months of first visit (women who first visit after 15/03/2013 excluded)   
 
Total 
n (Col %) n Row % 
Unadjusted Odds 
Ratio (95% CI) 
P-Value 
(LRT) 
Adjusted Odds Ratio 
(95% CI) 
P-Value 
(LRT) 
Total 9,540 4,622 48.5     
Period of first visit        
 Before 1st July 2011 4,566 (47.9) 2,432 53.3 Baseline  Baseline  
 After 1st July 2011 4,974 (52.1) 2,190 44.0 0.69 (0.57 - 0.84) <0.001 0.81 (0.69 - 0.95) 0.010 
Age        
 12-25 2,688 (28.4) 1,174 43.7 Baseline    
 26-35 4,318 (45.6) 2,161 50.1 1.29 (1.20 - 1.39)    
 36+ 2,472 (26.1) 1,273 51.5 1.37 (1.21 - 1.55) <0.001   
Education        
 None / Primary 1,442 (25.7) 637 44.2 Baseline  Baseline  
 Secondary 4,166 (74.3) 1,861 44.7 1.02 (0.88 - 1.18) 0.79 1.05 (0.93 - 1.20) 0.41 
Marital Status        
 Cohabiting/Married 161 (1.7) 77 47.8 0.97 (0.77 - 1.22)  0.90 (0.72 - 1.12)  
 Divorced/Separated 5,808 (61.1) 2,767 47.6 0.96 (0.89 - 1.03)  0.88 (0.80 - 0.97)  
 Never married 1,519 (16.0) 739 48.7 Baseline  Baseline  
 Widowed 2,017 (21.2) 1,020 50.6 1.08 (0.93 - 1.25) 0.13 0.91 (0.77 - 1.08) 0.013 
Baseline status        
 Never tested  3,147 (33.0) 1,277 40.6 Baseline  Baseline  
 Previous HIV- > 6 months ago 1,584 (16.6) 727 45.9 1.24 (1.05 - 1.47)  1.40 (1.23 - 1.59)  
 HIV - within 6 months 1,497 (15.7) 767  51.2 1.54 (1.39 - 1.70)  1.87 (1.70 - 2.06)  
 HIV+ & not on treatment 2,076 (21.8) 1,130 54.4 1.75 (1.58 - 1.93)  1.64 (1.37 - 1.98)  
 HIV + & on treatment 1,236 (13.0) 721 58.3 2.05 (1.86 - 2.25) <0.001 2.06 (1.76 - 2.41) <0.001 
Table 2: Odds ratios estimated using logistic regression with robust standard errors. Association with education and marital status adjusted for age; association with 
baseline status adjusted for age, education, and marital status. The association between period and return visits within 6 months was adjusted for by all the other variables. 
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Table 3: Longitudinal knowledge of HIV status among HIV-negatives; rate of starting antiretroviral medication among HIV-positives; HIV incidence  
  
% of time engaged in care 
“knowing status” among 
those who arrive HIV -ve 
 
Rate of starting ARV 
 
HIV incidence  
(Sero-conversion date estimated with tests 
after first visit only) 
 N (col %) PY /  
Total PY 
Mean proportion 
% (95% CI) 
N (col %) n/ 
100PY Rate / 100 PY 
Rate ratio 
 (95% CI) 
N (col %) n/100 PY Rate per 100 PY Rate ratio 
 (95% CI) 
Total 2,882 649/1,935 26.5 (23.4 - 29.5) 2,145 354/15.4 23.0 (19.3 - 26.9)  605 67/6.9 9.8 (7.1 - 15.9)  
Period of first visit            
 Before 1st July 2011 1,233 (42.8)  326/1,077 21.2 (19.2 - 23.1) 1,145 (53.4) 237/10.6 22.4 (19.8 - 27.0) Baseline 293 (48.4) 45/4.3 10.5 (8.0 - 16.0) Baseline 
 After 1st July 2011 1,649 (57.2) 323/858 30.4 (25.6 - 35.2) 1,000 (46.6) 117/4.8 24.3 (14.3 - 42.7) 1.08 (0.70 - 1.71) 312 (51.6) 22/2.6  8.6 (4.9 - 18.5) 0.82 (0.51 - 1.32) 
Age            
 12-25 1,029 (36.0) 230/656 28.6 (25.2 - 32.1) 461 (21.6) 41/3.3 12.3 (9.2 - 16.2) Baseline 223 (37.0) 27/2.5 10.8 (8.1 - 16.1) Baseline 
 26-35 1,233 (43.1) 281/869 24.8 (22.3 - 27.3) 1,138 (53.3) 196/8.2 23.9 (17.9 - 30.1) 1.94 (1.47 - 2.55) 262 (43.5) 32/3.0 10.7 (6.8 - 22.1) 0.99 (0.76 - 1.29) 
 36+ 598 (21.9) 135/403 26.3 (22.2 - 30.3) 536 (25.1) 116/3.8 30.4 (27.6 - 35.1) 2.47 (1.87 - 3.25) 118 (19.6) 8/1.3 6.0 (3.6 - 10.1) 0.56 (0.36 - 0.87) 
Education            
 None / Primary 409 (22.7) 81/208 30.0 (24.6 - 35.4) 321 (28.0) 44/1.6 28.1 (14.2 - 61.2) Baseline 77 (21.5) 4/0.7 5.7 (2.3 - 14.8) Baseline 
 Secondary 1,394 (77.3) 287/772 30.3 (25.7 - 34.9) 824 (72.0) 96/4.5 21.3 (14.1 - 32.5) 0.76 (0.51 - 1.12) 282 (78.6) 28/2.5 11.3 (7.5 - 18.4) 1.97 (0.85 - 4.57) 
Marital Status            
 Cohabiting/Married 82 (2.9) 16/48 24.6 (16.8 - 32.3) 43 (2.0) 7/0.3 24.4 (8.4 - 61.1) 1.38 (0.49 - 3.85) 14 (2.3) 1/0.1 7.3 (N/A - N/A) 0.79 (0.09 - 7.04) 
 Divorced/Separated 1,802 (62.9) 412/1,219 27.2 (23.5 – 31.0) 1,298 (61.0) 218/9.6 22.7 (18.1 - 28.1) 1.28 (0.84 - 1.94) 394 (65.7) 50/4.4 11.3 (8.3 - 17.4) 1.22 (0.63 - 2.36) 
 Never married 568 (19.8) 120/363 27.4 (23.4 - 31.4) 293 (13.8) 36/2.0 17.8 (11.1 - 26.9) Baseline 108 (18.0) 11/1.2 9.2 (4.8 - 24.2) Baseline 
 Widowed 414 (14.5) 95/293 22.2 (17.6 - 26.8) 495 (23.3) 92/3.4 26.9 (23.0 - 30.6) 1.52 (0.96 - 2.41) 84 (14.0) 5/1.0 4.8 (2.9 - 10.3) 0.52 (0.26 - 1.04) 
Baseline status            
 Never tested  1,022 (35.5) 170/664 19.9 (17.1 - 22.8) 509 (23.7) 89/3.3 26.8 (20.0 - 45.7) Baseline 159 (26.3) 23/1.9 11.9 (8.7 - 17.9) Baseline 
 HIV > 6 months ago 835 (29.0) 201/563 29.5 (26.2 - 32.9) 138 (6.4) 20/0.8 25.4 (16.1 - 40.1) 0.95 (0.62 - 1.44) 195 (32.2) 24/2.2 11.0 (6.9 - 20.8) 0.93 (0.57 - 1.50) 
 HIV - within 6 months 1,025 (35.6) 277/708 30.5 (26.0 - 34.9) 47 (2.2) 7/0.2 31.4 (17.6 - 55.6) 1.17 (0.64 - 2.14) 251 (41.5) 20/2.8 7.3 (4.9 - 13.4) 0.61 (0.43 – 0.87) 
HIV+ & not on treatment  N/A  1,451 (67.7) 238/11.1 21.5 (16.4 - 26.7) 0.80 (0.58 - 1.11) N/A N/A 
 
Table 3:All 95% confidence intervals are robust to clustering.  Extent of engagement with care, shown for women who arrive HIV-negative in terms of the amount of time 
knowing their HIV status (i.e. having been recently tested), and as the rate of uptake of ART for HIV-positive women.   Seroconversion date estimated as the midpoint 
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between positive test and last HIV-negative test.  Follow-up time from first to last HIV-negative test, or seroconversion date.  The incidence of HIV calculated from 
programme tests only was 12.5 (robust 95% CI 6.9 – 21.2), resulting from 24 cases and 193 person years. 
 
